Stockscreener 앱 받기
8.83
1.18%
0.09
전일 마감가:
$8.74
열려 있는:
$8.84
하루 거래량:
6,051
Relative Volume:
0.08
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.27%
1개월 성능:
-10.76%
6개월 성능:
-22.02%
1년 성능:
-22.23%
1일 변동 폭
$8.81
$8.90
1주일 범위
$8.59
$9.0479
52주 변동 폭
$8.59
$11.88
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
8.85 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
276.11 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
561.15 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
563.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
222.76 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
478.22 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf 주식(GNOM)의 최신 뉴스
SBI Securities Co. Ltd. Purchases Shares of 5,170 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Sanctuary Advisors LLC Takes $104,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Grid Metals (CVE:GRDM) Given a C$0.42 Price Target at Fundamental Research - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stake Reduced by Stratos Wealth Partners LTD. - Defense World
(GNOM) On The My Stocks Page - Stock Traders Daily
Top Canadian Genetics Stocks of 2025 - The Motley Fool Canada
(GNOM) Trading Advice - Stock Traders Daily
How To Trade (GNOM) - Stock Traders Daily
Stifel Financial Corp Reduces Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Jane Street Group LLC Sells 16,550 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Learn to Evaluate (GNOM) using the Charts - Stock Traders Daily
Rockefeller Capital Management L.P. Acquires Shares of 18,186 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Five Thematic Trends to Watch in 2025 - Saxo Bank
Best-Performing ETF Areas of Last Week - Yahoo Finance
Atria Investments Inc Invests $122,000 in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
When (GNOM) Moves Investors should Listen - Stock Traders Daily
Top Tech ETFs Right Now - Benzinga
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
The Next Big Theme: June 2024 - Global X
9 Best Biotech ETFs for 2024 - MSN
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - Nasdaq
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
What Is a Genomics ETF? A Complete Guide to the Breakthrough Biotech - etf.com
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Gene Therapy: A Cure for Cancer? - Opto RoW
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
3 Biotech ETFs to Bet on Now - Nasdaq
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 - InvestorPlace
The Next Big Theme: December 2023 - Global X
VettaFi Voices On: The Outlook for 2024 - ETF Trends
The Next Big Theme: November 2023 - Global X
Global X Genomics Biotechnology Etf (GNOM) 재무 분석
Global X Genomics Biotechnology Etf (GNOM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.47%
자본화:
|
볼륨(24시간):